Patent 11126025

Extensions

Patent term adjustments, term extensions, continuations, divisionals, family members, and expiration dates.

Active provider: Google · gemini-2.5-flash

Extensions

Patent term adjustments, term extensions, continuations, divisionals, family members, and expiration dates.

✓ Generated

To get detailed information on US Patent 11126025, including patent term adjustments (PTA), patent term extensions (PTE), continuation/divisional applications, related family members, and the projected expiration date, it is necessary to directly consult the USPTO Patent Center or Patent Public Search tools. The provided patent text and general search results offer some clues, but official USPTO records are the definitive source.

As a large language model, I do not have direct access to the live, real-time USPTO database to perform dynamic searches and retrieve specific document details like PTA calculations or family tree data with the level of certainty required. However, I can provide information on how these aspects are determined and what to look for based on the patent's filing and issue dates.

Here's what can be inferred and what would need direct USPTO database access:

Patent Term Adjustment (PTA):
PTA is granted by the USPTO to compensate for certain delays that occur during the patent examination process, such as the USPTO failing to meet specific deadlines (e.g., issuing a first office action within 14 months, issuing a patent within three years of filing). The USPTO automatically calculates and transmits a notice of PTA on or before the patent's issue date. To find the exact PTA for US11126025, one would need to check the patent's prosecution history in USPTO Patent Center.

Patent Term Extension (PTE):
PTE is a statutory remedy under 35 U.S.C. § 156 designed to compensate patentees for time lost due to mandatory pre-market regulatory review for certain products like pharmaceuticals and medical devices. Given that US11126025 relates to an "in-cell touch panel" and not a regulated product requiring FDA approval, it is highly unlikely to have received any PTE. Information on PTE is typically found in the "correction" section of the patent's images or in the electronic file wrapper in Patent Center.

Continuation and Divisional Applications:
Continuation and divisional applications are related applications filed by the same applicant. Continuation applications claim priority to an earlier non-provisional application and disclose an invention described in the earlier application. Divisional applications are filed for inventions disclosed in an earlier application but not claimed there. To identify any continuation or divisional applications for US11126025, one would need to search the USPTO database for applications that claim priority to the same initial application as US11126025 (US16/784,806). The "Related U.S. Application Data" section of the patent document itself often lists such relationships. The provided abstract and summary do not explicitly mention continuation or divisional applications, but they might exist in the full patent document.

Related Family Members:
The Google Patents page for US11126025 indicates that it claims priority from Japanese applications JP 2019-035692 and JP 2019-035902, both filed on February 28, 2019. These are foreign priority documents, making them part of the patent family. The "Other versions" section on Google Patents also lists US20200278571A1 as a related version, which is likely the published application for US11126025. To find a comprehensive list of all national and international family members, one would typically use tools like Espacenet or Global Dossier.

Projected Expiration Date:
For utility and plant patents filed after June 7, 1995, the term generally expires 20 years from the earliest filing date from which priority is claimed. For US11126025, the filing date is February 7, 2020, and the priority date is February 28, 2019 (from the Japanese applications). Therefore, the base expiration date would be 20 years from the earliest priority date.

  • Earliest Priority Date: February 28, 2019
  • Base Expiration Date (20 years from priority date): February 28, 2039

However, this date can be adjusted by:

  • Patent Term Adjustment (PTA): Any PTA awarded due to USPTO delays would extend this date.
  • Terminal Disclaimers: If a terminal disclaimer was filed, it could shorten the patent term.
  • Maintenance Fees: Timely payment of maintenance fees is required to keep the patent in force.

Without direct access to the USPTO's official records for US11126025, I cannot provide the exact PTA or definitively state if any terminal disclaimers were filed. However, the Google Patents page for US11126025 lists an "Anticipated expiration" date of 2040-02-07. This suggests that there has been an adjustment, likely due to Patent Term Adjustment (PTA), extending the term beyond the standard 20 years from the priority date. The difference between the calculated base expiration date (February 28, 2039) and the anticipated expiration date (February 7, 2040) is approximately one year, indicating that PTA was applied.

Generated 6/13/2026, 5:14:44 AM